Cambodia, Myanmar and Iran get EC medical technology aid:
This article was originally published in Clinica
Executive Summary
Medical technology features prominently in a E7.3m ($7.2m) package of humanitarian aid awarded last week to Cambodia, Myanmar and Iran. Under the European Union's ECHO programme, Cambodia will get E4.8m to provide essential supplies, including medical equipment, to help palliate "significant needs [in] access to healthcare" among its 7.5 million inhabitants. Most of the E2m awarded to Myanmar (formerly Burma) will be used to provide medical and diagnostics equipment, primarily to help fight malaria. There is a high prevalence of the disease among the country's more than 35 million population, with the most lethal strain accounting for 80% of cases. Iran will get E0.5m in medical kits and other supplies to help in its recovery from the earthquake of June 2002.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.